These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26982623)

  • 1. Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide.
    Haug BE; Camilio KA; Eliassen LT; Stensen W; Svendsen JS; Berg K; Mortensen B; Serin G; Mirjolet JF; Bichat F; Rekdal Ø
    J Med Chem; 2016 Apr; 59(7):2918-27. PubMed ID: 26982623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structural optimization of oncolytic peptide LTX-315.
    Song M; Liu Q; Yao JF; Wang YT; Ma YN; Xu H; Yu QY; Li Z; Du SS; Qi YK
    Bioorg Med Chem; 2024 Jun; 107():117760. PubMed ID: 38762978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three Rounds of Stability-Guided Optimization and Systematical Evaluation of Oncolytic Peptide LTX-315.
    Fu XY; Yin H; Chen XT; Yao JF; Ma YN; Song M; Xu H; Yu QY; Du SS; Qi YK; Wang KW
    J Med Chem; 2024 Mar; 67(5):3885-3908. PubMed ID: 38278140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LTX-315: a first-in-class oncolytic peptide that reprograms the tumor microenvironment.
    Sveinbjørnsson B; Camilio KA; Haug BE; Rekdal Ø
    Future Med Chem; 2017 Aug; 9(12):1339-1344. PubMed ID: 28490192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of novel peptides based on antimicrobial peptides as potential agents with antitumor and multidrug resistance-reversing activities.
    Zhang B; Shi W; Li J; Liao C; Yang L; Huang W; Qian H
    Chem Biol Drug Des; 2017 Nov; 90(5):972-980. PubMed ID: 28524273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumour evaluation of dolastatins 10 and 15 and their measurement in plasma by radioimmunoassay.
    Aherne GW; Hardcastle A; Valenti M; Bryant A; Rogers P; Pettit GR; Srirangam JK; Kelland LR
    Cancer Chemother Pharmacol; 1996; 38(3):225-32. PubMed ID: 8646796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells.
    Eike LM; Yang N; Rekdal Ø; Sveinbjørnsson B
    Oncotarget; 2015 Oct; 6(33):34910-23. PubMed ID: 26472184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor and antimetastatic effect of antimicrobial peptide conjugated with tumor homing peptide TMTP1 on the transplanted prostate cancer and gastric cancer in nude mice].
    Ma XY; Li S; Luo DF; Liu RH; Lu YP; Wang SX; Ma D; Xi L
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):737-41. PubMed ID: 24378093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Novel Class I Histone Deacetylase Inhibitors with Promising in Vitro and in Vivo Antitumor Activities.
    Yao Y; Tu Z; Liao C; Wang Z; Li S; Yao H; Li Z; Jiang S
    J Med Chem; 2015 Oct; 58(19):7672-80. PubMed ID: 26331334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective killing of cancer cells by peptide-targeted delivery of an anti-microbial peptide.
    Sioud M; Mobergslien A
    Biochem Pharmacol; 2012 Nov; 84(9):1123-32. PubMed ID: 22922046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical discovery of ixabepilone, a highly active antineoplastic agent.
    Lee FY; Borzilleri R; Fairchild CR; Kamath A; Smykla R; Kramer R; Vite G
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):157-66. PubMed ID: 18347795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aliphatic acid-conjugated antimicrobial peptides--potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability.
    Deng X; Qiu Q; Ma K; Wang X; Huang W; Qian H
    Org Biomol Chem; 2015 Jul; 13(28):7673-80. PubMed ID: 26083110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme-responsive oncolytic polypeptide for tumor therapy.
    Yin R; Wan P; Guo Z; Yi X; Zhang P; Shen W; Chen L; Xiao C; Chen X
    Acta Biomater; 2024 Jun; 181():415-424. PubMed ID: 38704115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthogonal assembly of a designed ankyrin repeat protein-cytotoxin conjugate with a clickable serum albumin module for half-life extension.
    Simon M; Frey R; Zangemeister-Wittke U; Plückthun A
    Bioconjug Chem; 2013 Nov; 24(11):1955-66. PubMed ID: 24168270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
    Bae DG; Kim TD; Li G; Yoon WH; Chae CB
    Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of poly(ethylene glycol) modification of HM-3 polypeptides.
    Zhou K; Zheng X; Xu HM; Zhang J; Chen Y; Xi T; Feng T
    Bioconjug Chem; 2009 May; 20(5):932-6. PubMed ID: 19413309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation.
    Ortuso F; Paduano F; Carotenuto A; Gomez-Monterrey I; Bilotta A; Gaudio E; Sala M; Artese A; Vernieri E; Dattilo V; Iuliano R; Brancaccio D; Bertamino A; Musella S; Alcaro S; Grieco P; Perrotti N; Croce CM; Novellino E; Fusco A; Campiglia P; Trapasso F
    ACS Chem Biol; 2013 Jul; 8(7):1497-506. PubMed ID: 23627474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of dihydropyrroloquinolines that selectively antagonize P-glycoprotein.
    Lee BD; Li Z; French KJ; Zhuang Y; Xia Z; Smith CD
    J Med Chem; 2004 Mar; 47(6):1413-22. PubMed ID: 14998330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity and pharmacokinetic properties of ARS-interacting multi-functional protein 1 (AIMP1/p43).
    Han JM; Myung H; Kim S
    Cancer Lett; 2010 Jan; 287(2):157-64. PubMed ID: 19573982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of New Monocarbonyl Ligustrazine-Curcumin Hybrids for Intervention of Drug-Sensitive and Drug-Resistant Lung Cancer.
    Ai Y; Zhu B; Ren C; Kang F; Li J; Huang Z; Lai Y; Peng S; Ding K; Tian J; Zhang Y
    J Med Chem; 2016 Mar; 59(5):1747-60. PubMed ID: 26891099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.